2018
DOI: 10.1016/j.hpb.2018.06.043
|View full text |Cite
|
Sign up to set email alerts
|

Surgical Resection for recurrence after two-stage hepatectomy for colorectal liver metastases is feasible, safe and improves survival

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…Repeat surgery for recurrence after two-stage hepatectomy Recurrence after two-stage hepatectomy is frequent because this approach is typically used for patients with multiple and bilateral CLMs 25,27,[34][35][36][37][38][39][40][41][42]. Two studies have focused on the prognosis of recurrence after two-stage hepatectomy 91,92. Imai et al reported that 38 patients (61%) underwent repeat surgery for recurrence after two-stage hepatectomy and patients who underwent repeat surgery had better OS than patients who did not (46% vs 26%, P = 0.004).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Repeat surgery for recurrence after two-stage hepatectomy Recurrence after two-stage hepatectomy is frequent because this approach is typically used for patients with multiple and bilateral CLMs 25,27,[34][35][36][37][38][39][40][41][42]. Two studies have focused on the prognosis of recurrence after two-stage hepatectomy 91,92. Imai et al reported that 38 patients (61%) underwent repeat surgery for recurrence after two-stage hepatectomy and patients who underwent repeat surgery had better OS than patients who did not (46% vs 26%, P = 0.004).…”
mentioning
confidence: 99%
“…Imai et al reported that 38 patients (61%) underwent repeat surgery for recurrence after two-stage hepatectomy and patients who underwent repeat surgery had better OS than patients who did not (46% vs 26%, P = 0.004). Lillemoe et al92 reported that 31 patients (37%) underwent resection for recurrence. RAS mutation and first recurrence in multiple sites were associated with worse survival.…”
mentioning
confidence: 99%